For stroke patients undergoing mechanical thrombectomy, adjunctive intra-arterial thrombolytics fell short for further ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational Device ...

Dr. Nima Aghaebrahim, a neurointerventionalist at Baptist Health, explains why "time is brain" when treating a stroke. Then, ...

Techniques for thrombus removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical catheter-directed thrombolysis). There are no ...

With video cameras in the ambulances, medical scientists can make today's stroke care even better for more patients. The same ...

AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a ...

Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be ...

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at ...

Inquis Medical, which is developing therapies for venous thromboembolic diseases, announced the completion of patient ...

MBG and STR were significantly improved in the thrombus aspiration group. In addition, manual thrombectomy was associated with a lower incidence of cardiac death and nonfatal re-infarction at 1 year.